Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Esteban Henao

Vascular Surgery Albuquerque, NM Medical Doctor

NPI 1881653277 CMS profile 445507

502 Elm St Ne, Albuquerque, NM 87102

Open in the dashboard

General payments

$112,886

665 records reported · program years 2019–2025

Research payments

$559

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$121,909 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Esteban Henao of Albuquerque, NM is reported in the CMS Open Payments database as having received $112,886 across 665 general payments and $559 in research payments paid to them. Separately, studies naming them as principal investigator received $121,909 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,550 61
2024 General $7,040 69
2023 General $12,130 99
2022 General $10,933 103
2021 General $23,220 88
2020 General $11,729 56
2020 Research $559 1
2019 General $45,286 189

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Esteban Henao
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Esteban Henao were reported at $2,550. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Esteban Henao Vascular Surgery median Middle half National median
2019 $45,286 $796 $226–$2,363 $163
2020 $11,729 $348 $118–$1,110 $114
2021 $23,220 $471 $158–$1,421 $132
2022 $10,933 $725 $222–$2,183 $149
2023 $12,130 $836 $257–$2,440 $160
2024 $7,040 $909 $252–$2,619 $164
2025 $2,550 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $52,321 198 payments
  2. Endologix, Inc. $29,532 97 payments
  3. W. L. Gore & Associates, Inc. $5,662 93 payments
  4. Abbott Laboratories $5,138 56 payments
  5. Silk Road Medical, Inc. $3,361 7 payments
  6. Asahi Intecc USA, Inc. $2,870 21 payments
  7. Shockwave Medical, Inc $2,746 6 payments
  8. Cardiovascular Systems Inc. $1,935 37 payments
  9. Medtronic, Inc. $1,900 36 payments
  10. LimFlow Inc. $1,508 7 payments
  11. Other $5,913 107 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $37,313 16 payments
  2. Consulting Fee $34,913 17 payments
  3. Food and Beverage $30,058 608 payments
  4. Travel and Lodging $8,103 22 payments
  5. Honoraria $1,500 1 payment
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $1,000 1 payment
Products named General payments · program years 2019–2025
  1. JETSTREAM $9,274 10 payments
  2. Ovation $8,616 26 payments
  3. Alto Abdominal Stent Graft System $7,260 14 payments
  4. ELUVIA Stents $6,716 21 payments
  5. GENERAL VASCULAR INTERVENTION $5,622 14 payments
  6. AngioJet Ultra 5000A $5,000 2 payments
  7. ELUVIA Eluvia_Pi $4,011 17 payments
  8. ENROUTE 0.014 Guidewire $3,090 3 payments
  9. ENROUTE Transcarotid Stent System $3,090 3 payments
  10. ENROUTE Transcarotid Neuroprotection System $3,090 3 payments
  11. Other $53,171 560 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Philips Electronics North America Corporation $559 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

96

Median for Vascular Surgery: 122

Drug cost

$1,439

Median for Vascular Surgery: $14,135

Branded share of claims

100%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 96 $1,439

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 84 billing codes

Paid by Medicare

$131,295

Medicare's payments for the services billed

Medicare patients

866

Average age 74

Services billed

1,669

457 women, 409 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Diabetes 39%
Chronic kidney disease 35%
Ischemic heart disease 33%
Depression 26%
Heart failure 24%
Atrial fibrillation 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

666 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record